Photo by diabetesmagazijn from unsplash
Diabetic cystopathy (DC) is recognized as one of the major etiologies of underactive bladder (UAB)/detrusor underactivity (DU). Although DC was first reported about three decades ago, there is a distinct… Click to show full abstract
Diabetic cystopathy (DC) is recognized as one of the major etiologies of underactive bladder (UAB)/detrusor underactivity (DU). Although DC was first reported about three decades ago, there is a distinct lack of effective pharmacological management methods for UAB/DU due to DC with a robust certainty of evidence. In this study, we investigated whether EP2 and EP3 receptors are promising targets of pharmacological management of UAB/DU due to DC.
Keywords:
diabetic cystopathy;
ep2 ep3;
underactive bladder;
ep3 receptors;
detrusor underactivity
Journal Title: LUTS: Lower Urinary Tract Symptoms
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: LUTS: Lower Urinary Tract Symptoms
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!